Efficacy of Neoadjuvant Intratumoral Darleukin/Fibromun (L19IL2 + L19TNF) in Patients with Clinical Stage IIIB/C Melanoma (Neo-DREAM)

Ann Surg Oncol. 2022 Jun;29(6):3377-3378. doi: 10.1245/s10434-022-11447-x. Epub 2022 Feb 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Melanoma* / drug therapy
  • Melanoma* / pathology
  • Melanoma* / surgery
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology
  • Treatment Outcome